Accelerating the drug regulatory process through a federated cloud ecosystem
A
Andrew S. Robertson
N
Nahid Latif
R
Raymond C. Votzmeyer
N
Natalie Tolli
M
Mark Taisey
K
Kevin Bugin
K
Kathy Williams
M
Michael Garvin
M
Max Wegner
A
Antoine Manson
J
Jennifer Dudinak
S
Sandra Krogulski
C
Carlos O. Garner
J
Jeffrey Francer
S
Sabine Luik
J
Jerry Stewart
K
Katrin Rupalla
G
Ginny Beakes-Read
S
Sean P. Curtis
J
Jayne Ware
K
Kevin Carl
N
Nicole Mahoney
D
Donna Boyce
D
David C. Isom
M
Michelle Rohrer
F
Fabio Bisordi
P
Peggy Lipp
L
Lina Aljuburi
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 25, Issue 4
Published
April 01, 2026
Pages
249-250
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (28)
A
Andrew S. Robertson
N
Nahid Latif
R
Raymond C. Votzmeyer
N
Natalie Tolli
M
Mark Taisey
K
Kevin Bugin
K
Kathy Williams
M
Michael Garvin
M
Max Wegner
A
Antoine Manson
J
Jennifer Dudinak
S
Sandra Krogulski
C
Carlos O. Garner
J
Jeffrey Francer
S
Sabine Luik
J
Jerry Stewart
K
Katrin Rupalla
G
Ginny Beakes-Read
S
Sean P. Curtis
J
Jayne Ware
K
Kevin Carl
N
Nicole Mahoney
D
Donna Boyce
D
David C. Isom
M
Michelle Rohrer
F
Fabio Bisordi
P
Peggy Lipp
L
Lina Aljuburi
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w